Literature DB >> 28757470

Molecular mechanisms of the mammalian Hippo signaling pathway.

Xin-yan Ji1, Guoxuan Zhong1, Bin Zhao2.   

Abstract

The Hippo pathway plays an evolutionarily conserved fundamental role in controlling organ size in multicellular organisms. Importantly, evidence from studies of patient samples and mouse models clearly indicates that deregulation of the Hippo signaling pathway plays a crucial role in the initiation and progression of many different types of human cancers. The Hippo signaling pathway is regulated by various stimuli, such as mechanical stress, G-protein coupled receptor signaling, and cellular energy status. When activated, the Hippo kinase cascade phosphorylates and inhibits the transcription co-activator YAP (Yes-associated protein), and its paralog TAZ (transcriptional coactivator with PDZ-binding motif), resulting in their cytoplasmic retention and degradation. When the Hippo signaling pathway is inactive, dephosphorylated YAP/TAZ translocate into the nucleus and activate gene transcription through binding to TEAD (TEA domain) family and other transcription factors. Such changes in gene expression promote cell proliferation and stem cell/progenitor cell self-renewal but inhibit apoptosis, thereby coordinately promote increase in organ size, tissue regeneration, and tumorigenesis. In this review, we summarize the molecular mechanisms of the mammalian Hippo signaling pathway with special emphasis on the Hippo kinase cascade and its upstream signals, the Hippo signaling pathway regulation of YAP and the mechanisms of YAP in regulation of gene transcription.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28757470     DOI: 10.16288/j.yczz.17-094

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  7 in total

1.  Circular RNA circRPPH1 promotes triple-negative breast cancer progression via the miR-556-5p/YAP1 axis.

Authors:  Yehui Zhou; Xiaorong Liu; Jing Lan; Yuqiu Wan; Xun Zhu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

2.  NF2 signaling pathway plays a pro-apoptotic role in β-adrenergic receptor stimulated cardiac myocyte apoptosis.

Authors:  Suman Dalal; Barbara Connelly; Mahipal Singh; Krishna Singh
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

3.  Competing endogenous RNA analysis reveals the regulatory potency of circRNA_036186 in HNSCC.

Authors:  Wen-Long Wang; Zhi Yang; Yi-Juan Zhang; Ping Lu; You-Kang Ni; Chang-Fu Sun; Fa-Yu Liu
Journal:  Int J Oncol       Date:  2018-07-24       Impact factor: 5.650

4.  Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.

Authors:  Jie Shen; Beibei Cao; Yatao Wang; Chenshen Ma; Zhuo Zeng; Liang Liu; Xiaolan Li; Deding Tao; Jianping Gong; Daxing Xie
Journal:  J Exp Clin Cancer Res       Date:  2018-07-28

5.  Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.

Authors:  Li-Cong Ma; Xu-Yang Tian; Fang Gao; Wen-Jie Dong; Tong Dang; Yan-Bin Jia
Journal:  BMC Gastroenterol       Date:  2020-05-18       Impact factor: 3.067

6.  RNF6 promotes the migration and invasion of breast cancer by promoting the ubiquitination and degradation of MST1.

Authors:  Yajuan Huang; Yufeng Zou; Zhigang Jie
Journal:  Exp Ther Med       Date:  2021-12-06       Impact factor: 2.751

7.  m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.

Authors:  Heng Zhang; Shao-Qiang Wang; Li Wang; Hang Lin; Jie-Bo Zhu; Ri Chen; Lin-Feng Li; Yuan-Da Cheng; Chao-Jun Duan; Chun-Fang Zhang
Journal:  Cell Death Dis       Date:  2022-07-28       Impact factor: 9.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.